ArticleJournal of neurodegenerative diseases2016

An Intrabody Drug (rAAV6-INT41) Reduces the Binding of N-Terminal Huntingtin Fragment(s) to DNA to Basal Levels in PC12 Cells and Delays Cognitive Loss in the R6/2 Animal Model.

I Alexandra Amaro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.